Successful treatment with low-dose gemtuzumab ozogamicin in combination chemotherapy followed by stem cell transplantation for children with refractory acute myeloid leukaemia

被引：6
作者：
Yoshida, Nao [1 ]
Sakaguchi, Hirotoshi [1 ]
Matsumoto, Kimikazu [1 ]
Kato, Koji [1 ]
机构：
[1] Japanese Red Cross Nagoya First Hosp, Dept Haematol & Oncol, Childrens Med Ctr, Nagoya, Aichi, Japan
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 2012年 / 158卷 / 05期
关键词：
gemtuzumab ozogamicin; children; refractory AML; stem cell transplantation; combination chemotherapy; VENOOCCLUSIVE DISEASE; RISK;
D O I：
10.1111/j.1365-2141.2012.09192.x
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：666 / 668
页数：3
相关论文
共 50 条
[41]   Dose-dependent effect of etoposide in combination with busulfan plus cyclophosphamide as conditioning for stem cell transplantation in patients with acute myeloid leukemia [J].
Kröger, N ;
Zabelina, T ;
Sonnenberg, S ;
Krüger, W ;
Renges, H ;
Stute, N ;
Finkenstein, F ;
Mayer, U ;
Holstein, K ;
Fiedler, W ;
Colberg, H ;
Sonnen, R ;
Kuse, R ;
Braumann, D ;
Metzner, B ;
del Valle, F ;
Erttmann, R ;
Kabisch, H ;
Zander, AR .
BONE MARROW TRANSPLANTATION, 2000, 26 (07) :711-716
[42]   Outcome of children relapsing after first allogeneic haematopoietic stem cell transplantation for acute myeloid leukaemia: a retrospective I-BFM analysis of 333 children [J].
Uden, Theodor ;
Bertaina, Alice ;
Abrahamsson, Jonas ;
Ansari, Marc ;
Balduzzi, Adriana ;
Bourquin, JeanPierre ;
Gerhardt, Corinne ;
Bierings, Marc ;
Hasle, Henrik ;
Lankester, Arjan ;
Mischke, Kirsten ;
Moore, Andrew S. ;
Nivison-Smith, Ian ;
Pieczonka, Anna ;
Peters, Christina ;
Sedlacek, Petr ;
Reinhardt, Dirk ;
Stein, Jerry ;
Versluys, Birgitta ;
Wachowiak, Jacek ;
Willems, Leen ;
Zimmermann, Martin ;
Locatelli, Franco ;
Sauer, Martin G. .
BRITISH JOURNAL OF HAEMATOLOGY, 2020, 189 (04) :745-750
[43]   The addition of gemtuzumab ozogamicin to low-dose Ara-C improves remission rate but does not significantly prolong survival in older patients with acute myeloid leukaemia: results from the LRF AML14 and NCRI AML16 pick-a-winner comparison [J].
Burnett, A. K. ;
Hills, R. K. ;
Hunter, A. E. ;
Milligan, D. ;
Kell, W. J. ;
Wheatley, K. ;
Yin, J. ;
McMullin, M. F. ;
Dignum, H. ;
Bowen, D. ;
Russell, N. H. .
LEUKEMIA, 2013, 27 (01) :75-81
[44]   The addition of gemtuzumab ozogamicin to low-dose Ara-C improves remission rate but does not significantly prolong survival in older patients with acute myeloid leukaemia: results from the LRF AML14 and NCRI AML16 pick-a-winner comparison [J].
A K Burnett ;
R K Hills ;
A E Hunter ;
D Milligan ;
W J Kell ;
K Wheatley ;
J Yin ;
M F McMullin ;
H Dignum ;
D Bowen ;
N H Russell .
Leukemia, 2013, 27 :75-81
[45]   Current Prophylaxis and Treatment Approaches for Acute Graft-Versus-Host Disease in Haematopoietic Stem Cell Transplantation for Children With Acute Lymphoblastic Leukaemia [J].
Woelfl, Matthias ;
Qayed, Muna ;
Benitez Carabante, Maria Isabel ;
Sykora, Tomas ;
Bonig, Halvard ;
Lawitschka, Anita ;
Diaz-de-Heredia, Cristina .
FRONTIERS IN PEDIATRICS, 2022, 9
[46]   Children with Relapsed or Refractory Nephroblastoma: Favorable Long-term Survival after High-dose Chemotherapy and Autologous Stem Cell Transplantation [J].
Illhardt, T. ;
Ebinger, M. ;
Schwarze, C. P. ;
Feuchtinger, T. ;
Furtwaengler, R. ;
Schlegel, P. G. ;
Klingebiel, T. ;
Greil, J. ;
Beck, J. F. ;
Handgretinger, R. ;
Lang, P. .
KLINISCHE PADIATRIE, 2014, 226 (6-7) :351-356
[47]   A Phase I Study of Gemtuzumab Ozogamicin (GO) in Combination with Busulfan and Cyclophosphamide (Bu/Cy) and Allogeneic Stem Cell Transplantation in Children with Poor-Risk CD33+ AML: A New Targeted Immunochemotherapy Myeloablative Conditioning (MAC) Regimen [J].
Satwani, Prakash ;
Bhatia, Monica ;
Garvin, James H., Jr. ;
George, Diane ;
Dela Cruz, Filemon ;
Le Gall, John ;
Jin, Zhezhen ;
Schwartz, Joseph ;
Duffy, Deirdre ;
van de Ven, Carmella ;
Foley, Sandra ;
Hawks, Rio ;
Morris, Erin ;
Baxter-Lowe, Lee Ann ;
Cairo, Mitchell S. .
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2012, 18 (02) :324-329
[48]   Re-induction with modified CLAG regimen in relapsed or refractory acute myeloid leukemia in children bridging to allogeneic hematopoietic stem cell transplantation [J].
Na Zhang ;
Jing-Bo Shao ;
Hong Li ;
Jing-Wei Yang ;
Kai Chen ;
Jia-Shi Zhu ;
Hui Jiang .
World Journal of Pediatrics, 2020, 16 :152-158
[49]   Re-induction with modified CLAG regimen in relapsed or refractory acute myeloid leukemia in children bridging to allogeneic hematopoietic stem cell transplantation [J].
Zhang, Na ;
Shao, Jing-Bo ;
Li, Hong ;
Yang, Jing-Wei ;
Chen, Kai ;
Zhu, Jia-Shi ;
Jiang, Hui .
WORLD JOURNAL OF PEDIATRICS, 2020, 16 (02) :152-158
[50]   A phase III clinical trial evaluating efficacy and safety of minimal residual disease-based risk stratification for children with acute myeloid leukemia, incorporating a randomized study of gemtuzumab ozogamicin in combination with post-induction chemotherapy for non-low-risk patients (JPLSG-AML-20) [J].
Tomizawa, Daisuke ;
Tsujimoto, Shin-ichi ;
Tanaka, Shiro ;
Matsubayashi, Jun ;
Aoki, Takahiro ;
Iwamoto, Shotaro ;
Hasegawa, Daisuke ;
Nagai, Kozo ;
Nakashima, Kentaro ;
Kawaguchi, Koji ;
Deguchi, Takao ;
Kiyokawa, Nobutaka ;
Ohki, Kentaro ;
Hiramatsu, Hidefumi ;
Shiba, Norio ;
Terui, Kiminori ;
Saito, Akiko Moriya ;
Kato, Motohiro ;
Taga, Takashi ;
Koshinaga, Tsugumichi ;
Adachi, Souichi .
JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2022, 52 (10) :1225-1231
12345